当前位置：首页 > 文献互助 > 互助详情

Real-World Safety Profile of Xanomeline-Trospium (Cobenfy), the First Muscarinic Agonist Antipsychotic: A Disproportionality Analysis of the FDA Adverse Event …复制

用户dO6Bp_vxHIqQ 16分钟前 4 10 求助中 帖子自动结束时间: 2026-07-29 11:36:21

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

H Farquhar
Available at SSRN 6611902
papers.ssrn.com
Background: Xanomeline-trospium (Cobenfy), the first antipsychotic with a non-dopaminergic mechanism approved in over 30 years, received FDA approval for schizophrenia in September 2024. Its muscarinic M1/M4 agonist mechanism may produce a different adverse event profile compared with conventional antipsychotics, but post-marketing data have not been comprehensively evaluated with active-comparator analyses. We aimed to characterise the safety profile of xanomeline-trospium using …

上一篇：Heparin: Physiology, Pharmacology, and Clinical Application

下一篇：Multifunctional applications and research advances of low-molecular-weight heparin

互助时间线

2026-07-24 11:36:21 [发起求助]

最新发布的求助

Multifunctional applications and research advances of low-molecular-weight heparin 14分钟前
Real-World Safety Profile of Xanomeline-Trospium (Cobenfy), the First Muscarinic Agonist Antipsychotic: A Disproportionality Analysis of the FDA Adverse Event … 16分钟前
Heparin: Physiology, Pharmacology, and Clinical Application 19分钟前
A real-world pharmacovigilance study of Xanomeline-Trospium events in the FDA adverse event reporting system (FAERS) 23分钟前
Post-marketing safety surveillance of the novel muscarinic antipsychotic Xanomeline-Trospium for schizophrenia: A comparative disproportionality analysis against … 26分钟前
Real-world use of xanomeline/trospium chloride in a large academic healthcare system in the first year following FDA approval 29分钟前
Effects of estriol administration on human postmenopausal endometrium. 45分钟前
Differences in Posterior Ocular Morphology Following Red Light Therapy Versus 0.01% Atropine for Myopia Control: A Randomized Controlled Trial Analysis 59分钟前
Highly Hydrophilic Polyurethane Foam Dressing Versus Early Hydrophilic Polyurethane Foam Dressing on Skin Graft Donor Site Healing in Patients with Diabetes: An Exploratory Clinical Trial 1小时前
Clinical assessment of a foam dressing containing growth factor-enhancing hydrated polyurethanes 1小时前
Copper-Catalyzed Cross-Coupling of Malonates with Aryl Halides Using Hydroxypicolinamide Ligands 2小时前
Epigenetic and 3D genome reprogramming during the aging of the human hippocampus 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com